|
EPS8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.39019956341735E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82527343134598E-12 |
| Normal-vs-Stage2 |
9.559200E-03 |
| Normal-vs-Stage3 |
1.448410E-02 |
| Normal-vs-Stage4 |
2.290800E-01 |
| Stage1-vs-Stage2 |
3.917200E-01 |
| Stage1-vs-Stage3 |
3.815000E-04 |
| Stage1-vs-Stage4 |
1.192790E-04 |
| Stage2-vs-Stage3 |
5.526100E-02 |
| Stage2-vs-Stage4 |
3.064000E-02 |
| Stage3-vs-Stage4 |
4.354800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.48539982933482E-10 |
| Normal-vs-AfricanAmerican |
4.237600E-01 |
| Normal-vs-Asian |
7.588300E-02 |
| Caucasian-vs-AfricanAmerican |
2.497400E-03 |
| Caucasian-vs-Asian |
4.258600E-01 |
| AfricanAmerican-vs-Asian |
2.578400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.47180000304093E-08 |
| Normal-vs-Female |
1.88262999999411E-05 |
| Male-vs-Female |
6.493400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.735200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.46410000181996E-08 |
| Normal-vs-Age(61-80Yrs) |
1.67899999999888E-05 |
| Normal-vs-Age(81-100Yrs) |
2.474300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.879100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.465600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.220380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.956400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.924600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.600400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.320420E-01 |
| Normal-vs-Grade 2 |
1.49059653509198E-11 |
| Normal-vs-Grade 3 |
1.760950E-04 |
| Normal-vs-Grade 4 |
8.424200E-01 |
| Grade 1-vs-Grade 2 |
4.460000E-01 |
| Grade 1-vs-Grade 3 |
6.261400E-01 |
| Grade 1-vs-Grade 4 |
1.651960E-01 |
| Grade 2-vs-Grade 3 |
2.570100E-04 |
| Grade 2-vs-Grade 4 |
2.52229999997411E-06 |
| Grade 3-vs-Grade 4 |
2.002400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62458935193399E-12 |
| Normal-vs-ccB subtype |
7.814500E-04 |
| ccA subtype-vs-ccB subtype |
1.936770E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69580000042302E-08 |
| Normal-vs-N1 |
4.896600E-01 |
| N0-vs-N1 |
5.390100E-02 |
|
|
